Why BofA Sees Strong Upside for Doximity (DOCS)

Doximity (NYSE:DOCS) is one of the most promising mid-cap healthcare stocks under $50.

On December 16, Bank of America analyst Allen Lutz reiterated his bullish stance on Doximity (NYSE:DOCS). He assigned a Buy rating to the stock with a $82 price target. This implies a highly attractive 88% upside potential for investors within the prevailing trading range.

Lutz attributed such upside to accelerating growth within the healthcare provider (HCP) budgets, as Doximity (NYSE:DOCS) has also been raising its budgetary allocation towards HCP advertising. He noted that such a shift towards HCP comes on the back of meager growth within direct-to-consumer (DTC) advertising. Another area of focus for Doximity (NYSE:DOCS) is the digital video initiatives, which are also a growth catalyst, as per experts.

As of December 19 closing, the consensus estimates reflect a positive analyst sentiment for Doximity (NYSE:DOCS), after the stock has dropped more than 18% in 2025. Of the 15 analyst ratings assigned to the stock, 8 were Buy calls, 5 were Hold calls, and only 2 were Sell calls. Analysts forecast a 1-year average price target of $66.62 per share, implying 52.6% upside from the current level.

Doximity (NYSE:DOCS) is a digital platform that provides online networking services for healthcare and medical professionals. The company has an extensive network currently covering around 80% of U.S.-based physicians. Their AI-powered application helps in efficient HIPAA-compliant communication among healthcare professionals.

READ NEXT:  Cathie Wood’s Stock Portfolio: Top 10 Stocks to Buy and 30 Most Fantastic Stocks Every Investor Should Pay Attention To.

Disclosure: None. This article is originally published at Insider Monkey.